Morrison Foerster

Morrison Foerster covers the pharmaceuticals, biologics, diagnostics, personalised medicine, medical devices, medicinal chemicals, and vaccines sectors. The firm is also lauded for its specialisms in IP protection, licensing, pharmacovigilance, and clinical and commercial supply agreements. Other key areas are US-China investigations, drug and device safety, cybersecurity, corruption, compliance, and cross-border transactions. The practice is co-led by managing partner of the Beijing and Shanghai offices, Chuan Sun, who acts for major life sciences clients, including healthcare private equity firms; and Hong Kong-based Gordon Milner, an expert in pharmaceutical and biotechnology industry-related technology projects. Beijing-based Sarah Wang advises on corporate commercial and technology transactions in the life sciences sector; while Chen Zhu and Tyler Xiu are other names in Hong Kong to note.